NO961816L - A process for preparing a virus-activated fraction containing factor VIII by chromatographic methods - Google Patents

A process for preparing a virus-activated fraction containing factor VIII by chromatographic methods

Info

Publication number
NO961816L
NO961816L NO961816A NO961816A NO961816L NO 961816 L NO961816 L NO 961816L NO 961816 A NO961816 A NO 961816A NO 961816 A NO961816 A NO 961816A NO 961816 L NO961816 L NO 961816L
Authority
NO
Norway
Prior art keywords
virus
factor viii
chromatographic methods
preparing
fraction containing
Prior art date
Application number
NO961816A
Other languages
Norwegian (no)
Other versions
NO961816D0 (en
NO317112B1 (en
Inventor
Ales Strancar
Monika Andrea Stadler
Djuro Josic
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6501733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO961816(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO961816L publication Critical patent/NO961816L/en
Publication of NO961816D0 publication Critical patent/NO961816D0/en
Publication of NO317112B1 publication Critical patent/NO317112B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A process for producing a virus-inactivated, factor VIII-containing fraction by chromatographic methods in which, starting with cryoprecipitate or blood plasma, possibly followed by a treatment with aluminium hydroxide, at least one separating operation is performed by membrane chromatography after the dissolution of the cryoprecipitate. The fractions are subjected to virus inactivation and preferably an additional pasteurisation step.
NO19961816A 1993-11-04 1996-05-03 A process for preparing a virus-activated fraction containing factor VIII by chromatographic methods NO317112B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4337573A DE4337573C1 (en) 1993-11-04 1993-11-04 Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods
PCT/EP1994/003258 WO1995012609A1 (en) 1993-11-04 1994-09-30 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods

Publications (3)

Publication Number Publication Date
NO961816L true NO961816L (en) 1996-05-03
NO961816D0 NO961816D0 (en) 1996-05-03
NO317112B1 NO317112B1 (en) 2004-08-16

Family

ID=6501733

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961816A NO317112B1 (en) 1993-11-04 1996-05-03 A process for preparing a virus-activated fraction containing factor VIII by chromatographic methods

Country Status (21)

Country Link
EP (1) EP0726907B1 (en)
JP (1) JP3739788B2 (en)
KR (1) KR960705841A (en)
CN (1) CN1109045C (en)
AT (1) ATE228533T1 (en)
AU (1) AU687451B2 (en)
CA (1) CA2175670C (en)
CZ (1) CZ290186B6 (en)
DE (2) DE4337573C1 (en)
ES (1) ES2182846T3 (en)
FI (1) FI116569B (en)
HU (1) HU222087B1 (en)
IL (1) IL111263A (en)
MY (1) MY113294A (en)
NO (1) NO317112B1 (en)
PL (1) PL181725B1 (en)
RU (1) RU2148411C1 (en)
SK (1) SK284215B6 (en)
UA (1) UA43855C2 (en)
WO (1) WO1995012609A1 (en)
ZA (1) ZA948667B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618851C1 (en) * 1996-05-10 1997-07-24 Octapharma Ag Testing factor VIII containing preparations
US6057164A (en) * 1996-03-08 2000-05-02 Octapharma Ag Process for testing suitability of protein fractions containing factor VIII
ES2137878B1 (en) * 1997-12-01 2000-10-01 Grifols Grupo Sa PROCEDURE FOR OBTAINING AN ATTENUATED HUMAN PLASMA OF VIRUSES FOR THERAPEUTIC USE.
CN102066417B (en) 2008-06-24 2015-11-25 奥克塔法马股份有限公司 The method of purification and solidification Factor IX
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3432083A1 (en) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg PASTEURIZED, ISOAGGLUTININ-FREE FACTOR VIII PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
JPS62191042A (en) * 1986-02-17 1987-08-21 Kanegafuchi Chem Ind Co Ltd Blood coagulation factor viii adsorbent and method for purifying blood coagulation factor viii using same
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
CA2001720C (en) * 1988-10-31 2001-10-02 Randal A. Goffe Membrane affinity apparatus and purification methods related thereto
EP0367840B1 (en) * 1988-11-05 1993-02-03 Octapharma AG Process for producing by chromatography a non-infectious antihemophilic factor with high purity
CH678155A5 (en) * 1989-08-09 1991-08-15 Fischer Ag Georg
AT399818B (en) * 1992-04-24 1995-07-25 Immuno Ag METHOD FOR PRODUCING A HIGH PURIFIED VIRUS-SAFE FACTOR VIII PREPARATION

Also Published As

Publication number Publication date
HU222087B1 (en) 2003-04-28
AU687451B2 (en) 1998-02-26
ATE228533T1 (en) 2002-12-15
DE59410213D1 (en) 2003-01-09
UA43855C2 (en) 2002-01-15
KR960705841A (en) 1996-11-08
SK284215B6 (en) 2004-11-03
EP0726907B1 (en) 2002-11-27
JPH09504532A (en) 1997-05-06
CZ290186B6 (en) 2002-06-12
SK56696A3 (en) 1996-10-02
CZ118796A3 (en) 1996-12-11
ES2182846T3 (en) 2003-03-16
CN1109045C (en) 2003-05-21
IL111263A (en) 2000-07-16
EP0726907A1 (en) 1996-08-21
FI961900A (en) 1996-05-03
RU2148411C1 (en) 2000-05-10
CA2175670C (en) 2005-08-02
ZA948667B (en) 1995-07-07
FI116569B (en) 2005-12-30
MY113294A (en) 2002-01-31
NO961816D0 (en) 1996-05-03
HUT76530A (en) 1997-09-29
PL314185A1 (en) 1996-09-02
IL111263A0 (en) 1994-12-29
CN1134157A (en) 1996-10-23
CA2175670A1 (en) 1995-05-11
JP3739788B2 (en) 2006-01-25
PL181725B1 (en) 2001-09-28
FI961900A0 (en) 1996-05-03
HU9601192D0 (en) 1996-06-28
NO317112B1 (en) 2004-08-16
AU7810994A (en) 1995-05-23
WO1995012609A1 (en) 1995-05-11
DE4337573C1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
GR3003819T3 (en)
UA27732C2 (en) Process for preparation of a standardized human von willebrand factor concentrate and a concentrate prepared thereby
DE359593T1 (en) CHROMATOGRAPHIC SEPARATION OF PLASMA PROTEINS.
DE69002395D1 (en) N-TERMINAL FRAGMENTS OF FUSION PROTEINS CONTAINING HUMAN SERUM ALBUMINE.
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
BR9913026A (en) Process for purifying recombinant papillomavirus virus-like particles (vlps), and process for preparing a purified human papillomavirus vlp product suitable for use in a human vaccine
DK0429570T3 (en) Osteoinducing preparations
DE69424545D1 (en) METHOD FOR PRODUCING IMMUNOGLOBULIN G CONCENTRATE
NO963785L (en) Process for the treatment of 5HT2B receptor-related conditions
HUT56858A (en) Process for producing from whole plasma concentrate of complex consisting of coagulation factor viii and von willebrand factor
NO961816L (en) A process for preparing a virus-activated fraction containing factor VIII by chromatographic methods
DE69510937D1 (en) METHOD FOR PRODUCING POLYHYDROXYALKANOATS BY MEANS OF CENTRIFUGAL FACTION
BR9206948A (en) Process for removing 2-chloro-1,1-difluorethylene and other unsaturated compounds from (R-1122) 1,1,1,2-tetra-fluoro-ethane and co-production of 2-chloro-1,1, 1,2-tetra-fluoro-ethane
EA199800685A1 (en) SEPARATION OF COMPONENTS OF BLOOD PLASMA BY MEANS OF FILTERING MEANS ON THE BASIS OF CELLULOSE
FI903366A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV EN MYCKET REN ICKE INFEKTIOES ANTIHEMOFILIFAKTOR GENOM KROMATOGRAFI.
AR018260A1 (en) A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS
ES2053619T3 (en) PROCEDURE FOR THE MANUFACTURE OF AN ANTIHEMOPHILIC FACTOR OF GREAT PURITY AND FREE OF VIRUSES THROUGH CHROMATOGRAPHY.
NO960396D0 (en) Process for Extraction of Periplasmic Proteins from Prokaryotic Microorganisms in the Presence of Arginine
ATE329602T1 (en) METHOD FOR PRODUCING PURIFIED TRANSFERRIN
DE59610629D1 (en) IMMUNOGENIC CONSTRUCT, METHOD FOR THE PRODUCTION AND USE THEREOF AS A VACCINE
UA27771C2 (en) Electrolytic cell (versions) and method for marking proteins, peptides and other organic molecules
ATE173503T1 (en) THE USE OF THE LEUKOCYTE ADHESION MOLECULE-1- FROM ENDOTHELIAL CELLS AND ANTIBODIES TO IT IN THE TREATMENT OF ASTHMA
DE59407666D1 (en) METHOD FOR PRODUCING 8-g (a), 12-OXIDO-13,14,15,16-TETRANORLABDANE
ES2094701A1 (en) Process for the production of antithrombin III
UA13922A (en) Method for producing of contrinsulinic factor, blocking of insulin binding with its receptor and having of diabetogenic action

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees